FDA Expands Use of Toujeo to Childhood Diabetes FDA Expands Use of Toujeo to Childhood Diabetes
First approved for US adults in 2015, Toujeo (insulin glargine 300 units/mL injection) may now be used in children as young as 6 years with type 1 or type 2 diabetes.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news
More News: Children | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Insulin | Lantus